Cloud Capital Management’s Alto Neuroscience ANRO Stock Holding History

Cloud Capital Management’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8	Closed	–	–	1561
2025 Q3	$0	Buy	+8	New	+$27	﹤0.01%	1572

Other funds holding ANRO

AWG

Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Cloud Capital Management's ANRO Position: Q4 2025 in Review

Cloud Capital Management sold out of Alto Neuroscience (ANRO) in Q4 2025, closing a stake of 8 shares.

Cloud Capital Management first reported a position in ANRO in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 97 funds tracked by Wall St. Rank hold ANRO as of Q4 2025.

Cloud Capital Management reported no remaining Alto Neuroscience position as of Q4 2025 after selling out during the quarter.
Cloud Capital Management sold 8 Alto Neuroscience shares in Q4 2025.
Cloud Capital Management first reported a position in Alto Neuroscience in Q3 2025 and held it in 1 quarter.
Cloud Capital Management's Alto Neuroscience position peaked at $0 in Q3 2025.
97 funds tracked by Wall St. Rank held Alto Neuroscience as of Q4 2025.

Based on Cloud Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.